Bank of New York Mellon
DARE icon

Bank of New York Mellon’s Dare Bioscience DARE Stock Holding History

Bank of New York Mellon’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,162
Closed -$8.72K – 4108
2024
Q2 		$8.72K Buy
2,162
+250
+13% +$1.21K ﹤0.01% 4103
2024
Q1 		$11.2K Sell
1,912
-334
-15% -$1.64K ﹤0.01% 4125
2023
Q4 		$8.33K Buy
2,246
+334
+17% +$1.53K ﹤0.01% 4274
2023
Q3 		$10.6K Hold
1,912
– – ﹤0.01% 4292
2023
Q2 		$20.9K Hold
1,912
– – ﹤0.01% 4284
2023
Q1 		$23.9K Sell
1,912
-250
-12% -$3.32K ﹤0.01% 4288
2022
Q4 		$21.5K Hold
2,162
– – ﹤0.01% 4346
2022
Q3 		$26K Buy
2,162
+53
+3% +$728 ﹤0.01% 4415
2022
Q2 		$31K Buy
2,109
+231
+12% +$3.48K ﹤0.01% 4444
2022
Q1 		$34K Buy
+1,878
New +$35.5K ﹤0.01% 4572
2017
Q3 		– Sell
-176
Closed -$9K – 4277
2017
Q2 		$9K Buy
176
+77
+78% +$4.47K ﹤0.01% 4270
2017
Q1 		$10K Buy
+99
New +$14.3K ﹤0.01% 4256
2016
Q4 		– Sell
-99
Closed -$13K – 4269
2016
Q3 		$13K Sell
99
-2
-2% -$448 ﹤0.01% 4240
2016
Q2 		$26K Buy
101
+3
+3% +$960 ﹤0.01% 4251
2016
Q1 		$32K Sell
98
-162
-62% -$45.7K ﹤0.01% 4134
2015
Q4 		$87K Buy
260
+162
+165% +$67.2K ﹤0.01% 4089
2015
Q3 		$43K Buy
+98
New +$49.3K ﹤0.01% 4257

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.95B AUM 22.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon's DARE Position: Q3 2024 in Review

Bank of New York Mellon sold out of Dare Bioscience (DARE) in Q3 2024, closing a stake of 2,162 shares — an estimated $8.72K sold.

Bank of New York Mellon first reported a position in DARE in Q3 2015 and held it in 17 quarters. The position peaked at $87K in Q4 2015. 22 funds tracked by Wall St. Rank hold DARE as of Q3 2024.

  • Bank of New York Mellon reported no remaining Dare Bioscience position as of Q3 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 2,162 Dare Bioscience shares in Q3 2024, an estimated $8.72K.
  • Bank of New York Mellon first reported a position in Dare Bioscience in Q3 2015 and held it in 17 quarters.
  • Bank of New York Mellon's Dare Bioscience position peaked at $87K in Q4 2015.
  • 22 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2024.

Based on Bank of New York Mellon's 13F filing for Q3 2024, filed 12 Nov 2024.